Castleman Disease: A Wide Spectrum of Thoracic Manifestations

Main Article Content

Giuseppe Mangiameli Ugo Cioffi Marco Alloisio Federica Carlea Alberto Testori

Abstract

Castleman’s disease is a benign lymphoproliferative disorder affecting both lymph nodes and extranodal loci. Castleman’s disease can occur in practically any part of the body, but it occurs mainly in the thorax (~70%) followed by the abdomen and pelvis, neck and axilla. Clinically, Castleman’s disease can be classified into a unicentric or multicentric form, depending on the number of lymph nodes involved, and histologically into a hyaline vascular variant, plasma cell, mixed cellular or plasmablastic variant. In this mini-review we briefly report and focus on all clinical thoracic manifestations of Castleman’s disease resuming for each of them the possible strategy of treatment.

Keywords: Castleman disease, mediastinal mass, lymphoproliferative disorder, thorax disease, mediastinal disease, surgical therapy

Article Details

How to Cite
MANGIAMELI, Giuseppe et al. Castleman Disease: A Wide Spectrum of Thoracic Manifestations. Medical Research Archives, [S.l.], v. 10, n. 5, june 2022. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/2829>. Date accessed: 05 nov. 2024. doi: https://doi.org/10.18103/mra.v10i5.2829.
Section
Research Articles

References

1. Takhar RP. Intrathoracic Castleman's disease: "An important clinical mimicker". Lung India. 2017 Mar-Apr;34(2):197-199. doi: 10.4103/lungindia.lungindia_419_15. PMID: 28360475; PMCID: PMC5351369.
2. Wu D, Lim MS, Jaffe ES. Pathology of Castleman Disease. Hematol Oncol Clin North Am. 2018 Feb;32(1):37-52. doi: 10.1016/j.hoc.2017.09.004. PMID: 29157618.
3. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956 Jul-Aug;9(4):822-30. doi: 10.1002/1097-0142(195607/08)9:4<822::aid-cncr2820090430>3.0.co;2-4. PMID: 13356266.
4. Talat N, Belgaumkar AP, Schulte KM. Surgery in Castleman's disease: a systematic review of 404 published cases. Ann Surg. 2012 Apr;255(4):677-84. doi: 10.1097/SLA.0b013e318249dcdc. PMID: 22367441.
5. Barua A, Vachlas K, Milton R, Thorpe JA. Castleman's disease - a diagnostic dilemma. J Cardiothorac Surg. 2014 Nov 28;9:170. doi: 10.1186/s13019-014-0170-0. PMID: 25431102; PMCID: PMC4255971.
6. Wojtyś M, Piekarska A, Kunc M, Ptaszyński K, Biernat W, Zaucha JM, et al. Clinicopathological comparison and therapeutic approach to Castleman disease-a case-based review. J Thorac Dis. 2019 Nov;11(11):4859-4874. doi: 10.21037/jtd.2019.10.73. PMID: 31903277; PMCID: PMC6940266.
7. Cervantes CE, Correa R. Castleman Disease: A Rare Condition with Endocrine Manifestations. Cureus. 2015 Nov 17;7(11):e380. doi: 10.7759/cureus.380. PMID: 26719823; PMCID: PMC4689570.
8. Tanaka O, Kiryu T, Hirose Y, Fujikake R, Sakurai K, Hoshi H. Chest wall Castleman's disease: CT and MRI findings. Radiat Med. 2006 Aug;24(7):529-33. doi: 10.1007/s11604-006-0063-9. PMID: 17058149.
9. McAdams HP, Rosado-de-Christenson M, Fishback NF, Templeton PA. Castleman disease of the thorax: radiologic features with clinical and histopathologic correlation. Radiology. 1998 Oct;209(1):221-8. doi: 10.1148/radiology.209.1.9769835. PMID: 9769835.
10. Moon WK, Im JG, Kim JS, Choi CG, Kim HC, Yeon KM, et al. Mediastinal Castleman disease: CT findings. J Comput Assist Tomogr. 1994 Jan-Feb;18(1):43-6. doi: 10.1097/00004728-199401000-00009. PMID: 8282881.
11. Parrot A, Bazelly B, Milleron BJ, Carette MF, Georges O, Akoun GM. Localisation thoracique inhabituelle d'une tumeur de Castleman. A propos d'une observation [Unusual thoracic localization of Castleman's tumor. Apropos of a case]. Rev Pneumol Clin. 1989;45(4):168-70. French. PMID: 2626630.
12. Fajgenbaum DC, Shilling D. Castleman Disease Pathogenesis. Hematol Oncol Clin North Am. 2018 Feb;32(1):11-21. doi: 10.1016/j.hoc.2017.09.002. PMID: 29157613.
13. El-Osta HE, Kurzrock R. Castleman's disease: from basic mechanisms to molecular therapeutics. Oncologist. 2011;16(4):497-511. doi: 10.1634/theoncologist.2010-0212. Epub 2011 Mar 25. PMID: 21441298; PMCID: PMC3228122.
14. van Rhee F, Stone K, Szmania S, Barlogie B, Singh Z. Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy. Clin Adv Hematol Oncol. 2010 Jul;8(7):486-98. PMID: 20864917.
15. Lomas OC, Streetly M, Pratt G, Cavet J, Royston D, Schey S, et al.; British Society for Haematology (BSH) Committee. The management of Castleman disease. Br J Haematol. 2021 Nov;195(3):328-337. doi: 10.1111/bjh.17688. Epub 2021 Aug 2. PMID: 34340261.
16. Legras A, Tallet A, Didelot A, Cazes A, Danel C, Hin A, et al. Clinical and molecular characteristics of unicentric mediastinal Castleman disease. J Thorac Dis. 2018 Apr;10(4):2079-2088. doi: 10.21037/jtd.2018.03.159. PMID: 29850111; PMCID: PMC5949489.
17. Biçakçioğlu P, Gülhan SŞ, Acar LN, Ağaçkiran Y, Özkara Ş, Kaya S, et al. Intrathoracic Castleman disease. Turk J Med Sci. 2014;44(2):197-202. doi: 10.3906/sag-1304-38. PMID: 25536724.
18. Talat N, Belgaumkar AP, Schulte KM. Surgery in Castleman's disease: a systematic review of 404 published cases. Ann Surg. 2012 Apr;255(4):677-84. doi: 10.1097/SLA.0b013e318249dcdc. PMID: 22367441.
19. Iyoda A, Yusa T, Hiroshima K, Fujisawa T, Ohwada H. Castleman's disease in the posterior mediastinum: report of a case. Surg Today. 2000;30(5):473-6. doi: 10.1007/s005950050629. PMID: 10819491.
20. Ma W, Li J, Zhang L. A case of idiopathic multicentric Castleman disease presenting with diffuse lung cysts: how to evaluate treatment response? Ann Hematol. 2020 Jun;99(6):1401-1402. doi: 10.1007/s00277-020-04030-5. Epub 2020 May 7. PMID: 32382769.
21. Huang H, Feng R, Li J, Song X, Li S, Xu K, et al. Castleman disease-associated diffuse parenchymal lung disease: A STROBE-compliant retrospective observational analysis of 22 cases in a tertiary Chinese hospital. Medicine (Baltimore). 2017 Sep;96(39):e8173. doi: 10.1097/MD.0000000000008173. PMID: 28953671; PMCID: PMC5626314.
22. Yue B, Huang J, Jing L, Yu H, Wei D, Zhang J, et al. Bilateral lung transplantation for Castleman disease with end-stage bronchiolitis obliterans. Clin Transplant. 2022 Jan;36(1):e14496. doi: 10.1111/ctr.14496. Epub 2021 Oct 21. PMID: 34590355.
23. Peng M, Shi J, Feng R. Multicentric Castleman Disease as a Rare Cause of Diffuse Lung Cysts. Am J Respir Crit Care Med. 2020 May 15;201(10):1292-1293. doi: 10.1164/rccm.201905-1067IM. PMID: 31914318.
24. Tanaka O, Kiryu T, Hirose Y, Fujikake R, Sakurai K, Hoshi H. Chest wall Castleman's disease: CT and MRI findings. Radiat Med. 2006 Aug;24(7):529-33. doi: 10.1007/s11604-006-0063-9. PMID: 17058149.
25. Ueda H, Kouso H, Tsukamoto S. Castleman's disease of the chest wall. J Thorac Oncol. 2009 Mar;4(3):426-8. doi: 10.1097/JTO.0b013e3181989edc. PMID: 19247090.
26. Reynolds SP, Gibbs AR, Weeks R, Adams H, Davies BH. Massive pleural effusion: an unusual presentation of Castleman's disease. Eur Respir J. 1992 Oct;5(9):1150-3. PMID: 1426226.
27. Wilkinson S, Forrester-Wood CP. Surgical resection of a solitary plasmacytoma originating in a rib of a patient with Castleman's disease. Ann Thorac Surg. 2003 Mar;75(3):1018-9. doi: 10.1016/s0003-4975(02)04476-4. PMID: 12645741.
28. Eloueriachi F, Caidi M, Zouaidia F, Ouchen F, Maidi M, Fennane H, et al. Maladie de Castleman: localisation inhabituelle du thorax [Castleman disease: unusual location of the chest]. Pan Afr Med J. 2012;12:111. French. Epub 2012 Aug 22. PMID: 23133711; PMCID: PMC3489394.
29. Rena O, Casadio C, Maggi G. Castleman's disease: unusual intrathoracic localization. Eur J Cardiothorac Surg. 2001 Apr;19(4):519-21. doi: 10.1016/s1010-7940(01)00613-3. PMID: 11306326.
30. Testori A, Voulaz E, Alloisio M, Errico V, Cariboni U, De Simone M, Cioffi U. Multicentric castleman's disease resembling metastatic lung carcinoma. A case report. Clin Case Rep. 2018 Jan 22;6(3):473-475. doi: 10.1002/ccr3.1381. PMID: 29531720; PMCID: PMC5838266.
31. Chan KL, Lade S, Prince HM, Harrison SJ. Update and new approaches in the treatment of Castleman disease. J Blood Med. 2016 Aug 3;7:145-58. doi: 10.2147/JBM.S60514. PMID: 27536166; PMCID: PMC4976903.